Estrogen Replacement Therapy and Ovarian Cancer
 

This prospective study of 31,381 postmenopausal women found those on long-term estrogen replacement therapy were more likely to develop epithelial ovarian cancer. The relative risk ratio was 1.7, i.e. women on estrogen replacement therapy had a 70% greater risk.

TITLE: Estrogen Replacement Therapy and Ovarian Cancer

REF: Epidemiology: Volume 15(1) January 2004 pp 100-104

URL: http://www.epidem.com/pt/re/epidemi...01000-00016.htm